Loading...

Ustekinumab for the treatment of psoriatic arthritis: an update

Psoriatic arthritis occurs in 30% of psoriasis patients, and the treatment can be challenging in some patients. Recently, the US Food and Drug Administration approved ustekinumab, a fully human monoclonal antibody, for the management of psoriatic arthritis. In this article, we review large-scale ran...

Full description

Saved in:
Bibliographic Details
Main Authors: Davari, Parastoo, Leo, Michael S, Kamangar, Faranak, Fazel, Nasim
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4158889/
https://ncbi.nlm.nih.gov/pubmed/25214798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S50003
Tags: Add Tag
No Tags, Be the first to tag this record!